Репозиторий Университета

© 2021, The Author(s). Background: The synaptic vesicle glycoprotein 2 (SV2) family is essential to the synaptic machinery involved in neurotransmission and vesicle recycling. The isoforms SV2A, SV2B and SV2C are implicated in neurological diseases such as epilepsy, Alzheimer’s and Parkinson’s disease. Suitable cell systems for studying regulation of these proteins are essential. Here we present gene expression data of SV2A, SV2B and SV2C in two human neuroblastoma cell lines after differentiation. Methods: Human neuroblastoma cell lines SiMa and IMR-32 were treated for seven days with growth supplements (B-27 and N-2), all-trans-retinoic acid (ATRA) or vasoactive intestinal peptide (VIP) and gene expression levels of SV2 and neuronal targets were analyzed. Results: The two cell lines reacted differently to the treatments, and only one of the three SV2 isoforms was affected at a time. SV2B and choline O-acetyltransferase (CHAT) expression was changed in concert after growth supplement treatment, decreasing in SiMa cells while increasing in IMR-32. ATRA treatment resulted in no detected changes in SV2 expression in either cell line while VIP increased both SV2C and dopamine transporter (DAT) in IMR-32 cells. Conclusion: The synergistic expression patterns between SV2B and CHAT as well as between SV2C and DAT mirror the connectivity between these targets found in disease models and knock-out animals, although here no genetic alteration was made. These cell lines and differentiation treatments could possibly be used to study SV2 regulation and function.

© 2021, The Author(s). Background: The synaptic vesicle glycoprotein 2 (SV2) family is essential to the synaptic machinery involved in neurotransmission and vesicle recycling. The isoforms SV2A, SV2B and SV2C are implicated in neurological diseases such as epilepsy, Alzheimer’s and Parkinson’s disease. Suitable cell systems for studying regulation of these proteins are essential. Here we present gene expression data of SV2A, SV2B and SV2C in two human neuroblastoma cell lines after differentiation. Methods: Human neuroblastoma cell lines SiMa and IMR-32 were treated for seven days with growth supplements (B-27 and N-2), all-trans-retinoic acid (ATRA) or vasoactive intestinal peptide (VIP) and gene expression levels of SV2 and neuronal targets were analyzed. Results: The two cell lines reacted differently to the treatments, and only one of the three SV2 isoforms was affected at a time. SV2B and choline O-acetyltransferase (CHAT) expression was changed in concert after growth supplement treatment, decreasing in SiMa cells while increasing in IMR-32. ATRA treatment resulted in no detected changes in SV2 expression in either cell line while VIP increased both SV2C and dopamine transporter (DAT) in IMR-32 cells. Conclusion: The synergistic expression patterns between SV2B and CHAT as well as between SV2C and DAT mirror the connectivity between these targets found in disease models and knock-out animals, although here no genetic alteration was made. These cell lines and differentiation treatments could possibly be used to study SV2 regulation and function.

Over recent years, mesenchymal stem/stromal cells (MSCs) and their potential biomedical applications have received much attention from the global scientific community in an increasing manner. Firstly, MSCs were successfully isolated from human bone marrow (BM), but in the next steps, they were also extracted from other sources, mostly from the umbilical cord (UC) and adipose tissue (AT). The International Society for Cellular Therapy (ISCT) has suggested minimum criteria to identify and characterize MSCs as follows: plastic adherence, surface expression of CD73, D90, CD105 in the lack of expression of CD14, CD34, CD45, and human leucocyte antigen-DR (HLA-DR), and also the capability to differentiate to multiple cell types including adipocyte, chondrocyte, or osteoblast in vitro depends on culture conditions. However, these distinct properties, including self-renewability, multipotency, and easy accessibility are just one side of the coin; another side is their huge secretome which is comprised of hundreds of mediators, cytokines, and signaling molecules and can effectively modulate the inflammatory responses and control the infiltration process that finally leads to a regulated tissue repair/healing or regeneration process. MSC-mediated immunomodulation is a direct result of a harmonic synergy of MSC-released signaling molecules (i.e., mediators, cytokines, and chemokines), the reaction of immune cells and other target cells to those molecules, and also feedback in the MSC-molecule-target cell axis. These features make MSCs a respectable and eligible therapeutic candidate to be evaluated in immune-mediated disorders, such as graft versus host diseases (GVHD), multiple sclerosis (MS), Crohn’s disease (CD), and osteoarthritis (OA), and even in immune-dysregulating infectious diseases such as the novel coronavirus disease 2019 (COVID-19). This paper discussed the therapeutic applications of MSC secretome and its biomedical aspects related to immune-mediated conditions. Sources for MSC extraction, their migration and homing properties, therapeutic molecules released by MSCs, and the pathways and molecular mechanisms possibly involved in the exceptional immunoregulatory competence of MSCs were discussed. Besides, the novel discoveries and recent findings on immunomodulatory plasticity of MSCs, clinical applications, and the methods required for their use as an effective therapeutic option in patients with immune-mediated/immune-dysregulating diseases were highlighted.

The family of Tribbles proteins play many critical nonenzymatic roles and regulate a wide range of key signaling pathways. Tribbles homolog 2 (Trib2) is a pseudo serine/threonine kinase that functions as a scaffold or adaptor in various physiological and pathological processes. Trib2 can interact with E3 ubiquitin ligases and control protein stability of downstream effectors. This protein is induced by mitogens and enhances the propagation of several cancer cells, including myeloid leukemia, liver, lung, skin, bone, brain, and pancreatic. Thus, Trib2 can be a predictive and valuable biomarker for the diagnosis and treatment of cancer. Recent studies have illustrated that Trib2 plays a major role in cell fate determination of stem cells. Stem cells have the capacity to self-renew and differentiate into specific cell types. Stem cells are important sources for cell-based regenerative medicine and drug screening. Trib2 has been found to increase the self-renewal ability of embryonic stem cells, the reprogramming efficiency of somatic cells, and chondrogenesis. In this review, we will focus on the recent advances of Trib2 function in tumorigenesis and stem cell fate decisions. [MediaObject not available: see fulltext.]

In the search for anti-SARS-CoV-2 drugs, much attention is given to safe and widely available native compounds. The green tea component epigallocatechin 3 gallate (EGCG) is particularly promising because it reportedly inhibits viral replication and viral entry in vitro. However, conclusive evidence for its predominant activity is needed. We tested EGCG effects on the native virus isolated from COVID-19 patients in two independent series of experiments using VERO cells and two different treatment schemes in each series. The results confirmed modest cytotoxicity of EGCG and its substantial antiviral activity. The preincubation scheme aimed at infection prevention has proven particularly beneficial. We complemented that finding with a detailed investigation of EGCG interactions with viral S-protein subunits, including S2, RBD, and the RBD mutant harboring the N501Y mutation. Molecular modeling experiments revealed N501Y-specific stacking interactions in the RBD-ACE2 complex and provided insight into EGCG interference with the complex formation. Together, these findings provide a molecular basis for the observed EGCG effects and reinforce its prospects in COVID-19 prevention therapy.

© 2021 Elsevier B.V. In this work, pristine Cu2O and Au nanoparticle modified Cu2O (Au/Cu2O) spherical nanocomposites were prepared by a simple redox method at room temperature. The as-prepared Cu2O nanospheres with diameters of 150–200 nm show relatively large surface area. The dye removal abilities of the pure Cu2O and the Au/Cu2O nanocomposites were tested by evaluating their adsorption and photocatalytic activities towards different aromatic molecules (e.g., Congo red (CR), Methyl orange (MO), Methyl blue (MB), Rhodamine B (RhB)). The experimental results indicate that the Au/Cu2O nanocomposites exhibit much superior adsorption and photocatalytic properties to the pristine Cu2O nanospheres. Among the catalysts, 1 wt% Au/Cu2O nanocomposite shows the best removal abilities to various dyes. Besides, the removal abilities towards these dyes are quite different from each other. For deep understanding of the adsorption mechanism, molecular dynamics (MD) caculations were conducted to investigate the adsorption energy of the Cu2O spheres by simulating the porous structure and Au modification. The calculation results indicate that CR and MO are chemically adsorbed on the Cu2O materials while the adsorption of MB and RhB are physical adsorption, which are well consistent with the experimental results. This study demonstrates the porous Cu2O based nanocomposites are promising materials with high adsorption and solar light-photocatalytic performance. In the meanwhile, the underlying mechanism on the superior dye removal abilities of Au modified Cu2O nanospheres were systematically discussed.

© 2020 The Author(s) Existing literature highlights the fact that patients with COVID-19 exhibit alterations in the coagulation process and are associated with respiratory and cardiovascular diseases, including acute respiratory distress syndrome and acute cor pulmonale. In this report, we describe the effects of systemic thrombolysis on acute cor pulmonale in a patient suffering from COVID-19. We demonstrated that systemic thrombolysis successfully improved the hemodynamics of our patient and resulted in a prominent reduction in hypercapnia, alveolar dead space, and ventilatory ratio.

© 2020 Elsevier Ltd COVID-19, coronavirus disease 2019, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a pandemic. At the time of writing this (October 14, 2020), more than 38.4 million people have become affected, and 1.0 million people have died across the world. The death rate is undoubtedly correlated with the cytokine storm and other pathological pulmonary characteristics, as a result of which the lungs cannot provide sufficient oxygen to the body's vital organs. While diversified drugs have been tested as a first line therapy, the complexity of fatal cases has not been reduced so far, and the world is looking for a treatment to combat the virus. However, to date, and despite such promise, we have received very limited information about the potential of nanomedicine to fight against COVID-19 or as an adjunct therapy in the treatment regimen. Over the past two decades, various therapeutic strategies, including direct-acting antiviral drugs, immunomodulators, a few non-specific drugs (simple to complex), have been explored to treat Acute Respiratory Distress Syndrome (ARDS), Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS), influenza, and sometimes the common flu, thus, correlating and developing specific drugs centric to COVID-19 is possible. This review article focuses on the pulmonary pathology caused by SARS-CoV-2 and other viral pathogens, highlighting possible nanomedicine therapeutic strategies that should be further tested immediately.

© 2020 Elsevier Ltd COVID-19, coronavirus disease 2019, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a pandemic. At the time of writing this (October 14, 2020), more than 38.4 million people have become affected, and 1.0 million people have died across the world. The death rate is undoubtedly correlated with the cytokine storm and other pathological pulmonary characteristics, as a result of which the lungs cannot provide sufficient oxygen to the body's vital organs. While diversified drugs have been tested as a first line therapy, the complexity of fatal cases has not been reduced so far, and the world is looking for a treatment to combat the virus. However, to date, and despite such promise, we have received very limited information about the potential of nanomedicine to fight against COVID-19 or as an adjunct therapy in the treatment regimen. Over the past two decades, various therapeutic strategies, including direct-acting antiviral drugs, immunomodulators, a few non-specific drugs (simple to complex), have been explored to treat Acute Respiratory Distress Syndrome (ARDS), Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS), influenza, and sometimes the common flu, thus, correlating and developing specific drugs centric to COVID-19 is possible. This review article focuses on the pulmonary pathology caused by SARS-CoV-2 and other viral pathogens, highlighting possible nanomedicine therapeutic strategies that should be further tested immediately.

© 2020 Elsevier Inc. Objectives: Efficacy and safety of corticosteroids in patients with 2019-nCoV (novel coronavirus 2019) infection still are debated. Because large randomized clinical trials (RCTs) and a well-conducted meta-analysis on the use of corticosteroids, focused on patients with coronavirus disease (COVID-19) in intensive care units, recently were published, a meta-analysis of RCTs on corticosteroids therapy in patients with different disease severity was performed to evaluate the effect on survival. Design: A meta-analyses of RCTs was performed. Setting: Patients admitted to hospital. Participants: Patients with coronavirus disease. Interventions: Administration of corticosteroids. Measurements and Main Results: A search was performed for RCTs of adult patients with acute hypoxemic failure related to 2019-nCoV infection who received corticosteroids versus any comparator. The primary endpoint was mortality rate. Five RCTs involving 7,692 patients were included. Overall mortality of patients treated with corticosteroids was slightly but significantly lower than mortality of controls (26% v 28%, relative risk {RR} = 0.89 [95% confidence interval {CI} 0.82-0.96], p = 0.003). The same beneficial effect was found in the subgroup of patients requiring mechanical ventilation (RR = 0.85 [95% CI 0.72-1.00], p = 0.05 number needed to treat {NNT} = 19). Remarkably, corticosteroids increased mortality in the subgroup of patients not requiring oxygen (17% v 13%, RR = 1.23 [95% CI 1.00-1.62], p = 0.05 number needed to harm {NNH} = 29). Tests for comparison between mechanically ventilated subgroups and those not requiring oxygen confirmed that treatment with corticosteroids had a statistically significant different effect on survival. Patients treated with corticosteroids had a significantly lower risk of need for mechanical ventilation. Conclusions: Corticosteroids may be considered in severe critically ill patients with COVID-19 but must be discouraged in patients not requiring oxygen therapy. Urgently, further trials are warranted before implementing this treatment worldwide.

Copyright © 2021 The Korean Academy of Asthma, Allergy and Clinical Immunology. Arginine kinase (AK) was first identified as an allergen in the Indian-meal moth and subsequently shown to occur as allergen in various invertebrates and shellfish. The cDNA coding for AK from the house dust mite (HDM) species Dermatophagoides pteronyssinus, Der p 20, has been isolated, but no recombinant Der p 20 (rDer p 20) allergen has been produced and characterized so far. We report the expression of Der p 20 as recombinant protein in Escherichia coli. rDer p 20 was purified and shown to be a monomeric, folded protein by size exclusion chromatography and circular dichroism spectroscopy, respectively. Using AK-specific antibodies, Der p 20 was found to occur mainly in HDM bodies, but not in fecal particles. Thirty percent of clinically well-characterized HDM allergic patients (n = 98) whose immunoglobulin E (IgE) reactivity profiles had been determined with an extensive panel of purified HDM allergens (Der f 1, 2; Der p 1, 2, 4, 5, 7, 10, 11, 14, 15, 18, 21, 23 and 37) showed IgE reactivity to Der p 20. IgE reactivity to Der p 20 was more frequently associated with lung symptoms. AKs were detected in several invertebrates with specific antibodies and Der p 20 showed IgE cross-reactivity with AK from shrimp (Litopenaeus vannamei). Thus, Der p 20 is a cross-reactive HDM allergen and may serve as a diagnostic marker for HDM-induced lung symptoms such as asthma.

Copyright © 2021 The Korean Academy of Asthma, Allergy and Clinical Immunology. Arginine kinase (AK) was first identified as an allergen in the Indian-meal moth and subsequently shown to occur as allergen in various invertebrates and shellfish. The cDNA coding for AK from the house dust mite (HDM) species Dermatophagoides pteronyssinus, Der p 20, has been isolated, but no recombinant Der p 20 (rDer p 20) allergen has been produced and characterized so far. We report the expression of Der p 20 as recombinant protein in Escherichia coli. rDer p 20 was purified and shown to be a monomeric, folded protein by size exclusion chromatography and circular dichroism spectroscopy, respectively. Using AK-specific antibodies, Der p 20 was found to occur mainly in HDM bodies, but not in fecal particles. Thirty percent of clinically well-characterized HDM allergic patients (n = 98) whose immunoglobulin E (IgE) reactivity profiles had been determined with an extensive panel of purified HDM allergens (Der f 1, 2; Der p 1, 2, 4, 5, 7, 10, 11, 14, 15, 18, 21, 23 and 37) showed IgE reactivity to Der p 20. IgE reactivity to Der p 20 was more frequently associated with lung symptoms. AKs were detected in several invertebrates with specific antibodies and Der p 20 showed IgE cross-reactivity with AK from shrimp (Litopenaeus vannamei). Thus, Der p 20 is a cross-reactive HDM allergen and may serve as a diagnostic marker for HDM-induced lung symptoms such as asthma.

© 2020 The Authors. Journal of Cellular Physiology published by Wiley Periodicals LLC SLC2A3 encodes the predominantly neuronal glucose transporter 3 (GLUT3), which facilitates diffusion of glucose across plasma membranes. The human brain depends on a steady glucose supply for ATP generation, which consequently fuels critical biochemical processes, such as axonal transport and neurotransmitter release. Besides its role in the central nervous system, GLUT3 is also expressed in nonneural organs, such as the heart and white blood cells, where it is equally involved in energy metabolism. In cancer cells, GLUT3 overexpression contributes to the Warburg effect by answering the cell's increased glycolytic demands. The SLC2A3 gene locus at chromosome 12p13.31 is unstable and prone to non-allelic homologous recombination events, generating multiple copy number variants (CNVs) of SLC2A3 which account for alterations in SLC2A3 expression. Recent associations of SLC2A3 CNVs with different clinical phenotypes warrant investigation of the potential influence of these structural variants on pathomechanisms of neuropsychiatric, cardiovascular, and immune diseases. In this review, we accumulate and discuss the evidence how SLC2A3 gene dosage may exert diverse protective or detrimental effects depending on the pathological condition. Cellular states which lead to increased energetic demand, such as organ development, proliferation, and cellular degeneration, appear particularly susceptible to alterations in SLC2A3 copy number. We conclude that better understanding of the impact of SLC2A3 variation on disease etiology may potentially provide novel therapeutic approaches specifically targeting this GLUT.

© 2020 Synthesis of high energy density and long durability electrode materials are huge urgency for futuristic hybrid supercapacitors (HSCs). In the present work, self-assembled three-dimensional (3D)-mesoporous regimented pristine and neodymium (Nd) doped α-Mn2O3 microspheres (MSs) are prepared by simple hydrothermal method. Due to uniform morphology, presence of oxygen vacancies, mesoporous robust structure, and optimum doping (Nd5%-doped Mn2O3 3D-MSs) offers a high specific capacitance of 862.14 F g−1 (431.07 C g−1) at 0.5 A g−1 with superior cycling retention of 97.30% after 2000 cycles. Additionally, a pouch-type HSC device is fabricated using Nd5%-Mn2O3 3D-MSs as a battery-type positive electrode and activated carbon (AC) as a capacitive-type negative electrode. The fabricated device delivers a maximum energy density of 32.26 Wh kg−1 at a power density of 800 W kg−1 with superior cyclic retention and exhibit a little loss of 4.56% after 10,000 cycles. This superior performance is due to robust microstructures that can alleviate swelling and shrinking of active material at cycling test. Two pouch-type HSCs are connected in series to power light-emitting diodes (LEDs) for real-time applicability. Overall, this study demonstrates that rational doping, porous architecture, oxygen vacancies, and robust micro-nano structure greatly assist to achieve high energy density as well as long life HSCs devices.

© 2020 Cigarette butts (CBs) represent the most common, though poorly biodegradable, type of waste on Earth. Thrown on the soil surface, they can remain unchanged for years, poisoning surrounding ecosystems with toxins accumulated during the smoking process. However, there is practically no data on the effect of smoked CBs on soil biota or soil animals in particular, nor on the potential of edaphic fauna to facilitate their decomposition. One of the most promising agents among soil animals are earthworms, which are known to be beneficial in the processes of recalcitrant organic matter degradation and stimulation of microbial activity in detrital food webs. In a microcosm experiment with the sod podzolic soil, we aimed at testing the effect of the commonly cultured epigeic earthworm Eisenia fetida (Savigny 1826) on the biodegradation rate of CBs and the possible adverse effects of this waste on the species. The experiment had a full-factorial design with three categorical predictors: CB number (0, 1 and 3 per microcosm); smoking condition (smoked and unsmoked CBs) and two levels of earthworm amendment (0 and 4 per microcosm). During 70 days of the experiment, we did not observe any smoked CB-induced mortality of earthworms. The addition of E. fetida significantly increased the CB mass loss across all treatment combinations. Specifically, earthworms improved the decomposition rate from 30 to 36% (p < 0.05), on average. However, this improvement was mainly associated with CB paper wrapping consumption. The inhibition of CO2 emission in microcosms with CBs and earthworms suggested the direct consumption of this waste by E. fetida, rather than modulation of the degradation potential of a microbial community. E. fetida appears to thus be a moderately promising agent for CB biodegradation with the simultaneous reduction in carbon loss from soil through the microbial channel in the studied soil type. These results open perspectives for the further evaluation of the role of soil macroinvertebrates in recalcitrant organic waste management in general and CBs in particular. We demonstrated that earthworms can efficiently decompose smoked and unsmoked cigarette butts regardless of their toxic potential and simultaneously reduce associated microbial activity.

© 2020 A series of novel metal complexes of Cu(II), Ni(II), Zn(II), Cd(II), and Mg(II) with four N-heterocyclic derivatives of 2-arylhydrazono-1,3-dicarbonyl compounds were isolated and identified by FT IR, 1H NMR, EPR, and UV–Vis spectroscopy. The crystallographic data for two organic ligands as well as Mg(II) and Ni(II) complexes were obtained. It was indicated that the organic species exist in the form of hydrazo-tautomers. The Ni complex is monomeric and is characterized by the tridentate coordination of the ligand through a deprotonated N-atom of the hydrazo-fragment and two neighboring O-atoms of the carbonyl and deprotonated hydroxy-groups. In the case of the Mg complex the polymeric structure is observed with the additional coordination through the sulfamide group of the organic specie. Formation constants of the complexes in ethanol aqueous solutions were calculated and correlated with some physical characteristics of the metal cations. Structures of yet unstudied metal complexes were proposed based on quantum-chemical modeling at the DFT/B3LYP level.

© 2020 A series of novel metal complexes of Cu(II), Ni(II), Zn(II), Cd(II), and Mg(II) with four N-heterocyclic derivatives of 2-arylhydrazono-1,3-dicarbonyl compounds were isolated and identified by FT IR, 1H NMR, EPR, and UV–Vis spectroscopy. The crystallographic data for two organic ligands as well as Mg(II) and Ni(II) complexes were obtained. It was indicated that the organic species exist in the form of hydrazo-tautomers. The Ni complex is monomeric and is characterized by the tridentate coordination of the ligand through a deprotonated N-atom of the hydrazo-fragment and two neighboring O-atoms of the carbonyl and deprotonated hydroxy-groups. In the case of the Mg complex the polymeric structure is observed with the additional coordination through the sulfamide group of the organic specie. Formation constants of the complexes in ethanol aqueous solutions were calculated and correlated with some physical characteristics of the metal cations. Structures of yet unstudied metal complexes were proposed based on quantum-chemical modeling at the DFT/B3LYP level.

© 2020 This work is dedicated to the influence of thermal treatment procedures in vacuum and air atmosphere on the structural features of multiwalled TiO2 anodic nanotubes (NTs) formed in fluorine-containing ethylene glycol (EG) based electrolyte investigated by high-resolution transmission electron microscopy (HRTEM) in conjunction with EDX and electronic nanodiffraction (STEM nanodiffraction), IR and Raman spectroscopy, XPS and ToF SIMS. Using electron nanodiffraction technique, there were estimated TiO2 nanocrystallite sizes for the inner layer of the NTs after annealing in air and vacuum for the first time. The differences in carbon distribution profiles in TiO2 nanotube crosscut after thermal treatments in air and vacuum were discussed. It was found that thermal treatment in vacuum leads to different phase composition of TiO2 NTs IL comparing to annealing in air. A sequential thermal treatment (firstly in vacuum and then in air) enables to remove carbon from TiO2 NTs surface and partly from TiO2 NTs IL and prevent detachment of IL from OL at the same time. The obtained data will be useful for understanding the mechanisms of structural modifications during thermal treatments as well as for functional properties optimization of such nanostructures.

© 2020 Wiley Periodicals, Inc. Performance optimization of electrode materials for lithium-ion batteries is one the most important scientific problems. In this paper, we suggest structural design of γ-Fe2O3/CNT composite for increase of its quantum capacitance that is required by modern energy storage devices capable of quick transfer or accumulation of energy and ensuring long-term autonomous operation. For this goal, we investigate the specific quantum capacitance of the γ-Fe2O3/CNT composites with a different content of maghemite by quantum chemical methods. The content of maghemite is varied by length of CNTs as well as by number of γ-Fe2O3 unit cell the weight ratio equals 13.71%, 20.74%, 26.69%, and 34.30%. It is found that the quantum capacitance grows with increasing maghemite concentration. Calculations show that the value of QC at the Fermi level for γ-Fe2O3/CNT is correlated with the theoretical specific capacity of the material. Proposed in this work approach to calculating the quantum capacitance with further analysis of its dependence on voltage can be an effective tool for optimizing the content of the composite with the aim of balancing the Faradaic and non-Faradaic component of its functional activity.